Acinic cell carcinoma future or investigational therapies

Jump to: navigation, search

Acinic cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acinic cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Surgery

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Acinic cell carcinoma future or investigational therapies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acinic cell carcinoma future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acinic cell carcinoma future or investigational therapies

CDC on Acinic cell carcinoma future or investigational therapies

Acinic cell carcinoma future or investigational therapies in the news

Blogs on Acinic cell carcinoma future or investigational therapies

Directions to Hospitals Treating Acinic cell carcinoma

Risk calculators and risk factors for Acinic cell carcinoma future or investigational therapies

Overview

Finding a good chemotherapy regimen for distant metastasis, molecular methodology by the concept of MASC, links between genetic and disease, the role of S-100 protein in salivary gland pathologies are fields of further research.

Future or Investigational Therapies

  • Finding a good chemotherapy regimen for distant metastasis is necessary, since far metastasis, specially lungs, have been involved in a great portion of patients.[1]
  • Molecular methodology by the concept of MASC need further thinking and research.
  • Links between genetic and disease is still uncertain.
  • The role of S-100 protein in salivary gland pathologies is still not very well understood.

References

  1. Vander Poorten, V.; Triantafyllou, A.; Thompson, L. D. R.; Bishop, J.; Hauben, E.; Hunt, J.; Skalova, A.; Stenman, G.; Takes, R. P.; Gnepp, D. R.; Hellquist, H.; Wenig, B.; Bell, D.; Rinaldo, A.; Ferlito, A. (2015). "Salivary acinic cell carcinoma: reappraisal and update". European Archives of Oto-Rhino-Laryngology. 273 (11): 3511–3531. doi:10.1007/s00405-015-3855-7. ISSN 0937-4477.

Linked-in.jpg